| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,183 |
54,061 |
$2.44M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,262 |
14,451 |
$979K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,139 |
1,088 |
$385K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,863 |
5,293 |
$320K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,626 |
5,182 |
$317K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,687 |
3,359 |
$181K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,114 |
2,673 |
$150K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,334 |
11,045 |
$145K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
372 |
342 |
$134K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,892 |
4,739 |
$105K |
| 92551 |
|
15,496 |
13,757 |
$95K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,198 |
1,131 |
$89K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,346 |
7,366 |
$85K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,260 |
6,637 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,047 |
1,783 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
794 |
754 |
$54K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,050 |
1,510 |
$41K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,049 |
1,506 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,075 |
5,526 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,685 |
3,267 |
$33K |
| 99051 |
|
3,025 |
2,781 |
$32K |
| 99173 |
|
15,947 |
14,293 |
$19K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
813 |
611 |
$16K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,092 |
924 |
$16K |
| 81002 |
|
6,671 |
5,621 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
462 |
446 |
$10K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
170 |
169 |
$9K |
| 81025 |
|
2,005 |
1,700 |
$8K |
| 87807 |
|
799 |
702 |
$7K |
| 99460 |
|
167 |
164 |
$7K |
| 85018 |
|
3,823 |
3,409 |
$7K |
| 83655 |
|
655 |
625 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,440 |
1,059 |
$6K |
| 96127 |
|
1,878 |
1,321 |
$5K |
| 99381 |
|
139 |
133 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
40 |
$2K |
| 94761 |
|
2,234 |
1,848 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,893 |
1,588 |
$2K |
| 99050 |
|
81 |
80 |
$866.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
83 |
71 |
$659.88 |
| 96161 |
|
155 |
124 |
$537.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,823 |
1,496 |
$355.39 |
| 81003 |
|
204 |
191 |
$317.29 |
| 99384 |
|
15 |
15 |
$270.57 |
| 90474 |
|
25 |
25 |
$219.12 |
| 99441 |
|
31 |
30 |
$198.17 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
46 |
24 |
$55.00 |
| 94760 |
|
35 |
28 |
$23.73 |
| 90634 |
|
1,857 |
1,785 |
$17.77 |
| 90723 |
|
602 |
580 |
$0.00 |
| 90619 |
|
603 |
497 |
$0.00 |
| 90680 |
|
753 |
727 |
$0.00 |
| 90697 |
|
145 |
139 |
$0.00 |
| 90696 |
|
254 |
251 |
$0.00 |
| 90686 |
|
518 |
513 |
$0.00 |
| 90716 |
|
86 |
81 |
$0.00 |
| A9150 |
Non-prescription drugs |
29 |
28 |
$0.00 |
| 90698 |
|
26 |
26 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
28 |
27 |
$0.00 |
| 90648 |
|
854 |
824 |
$0.00 |
| 90670 |
|
1,517 |
1,473 |
$0.00 |
| 90734 |
|
1,386 |
1,338 |
$0.00 |
| 90671 |
|
289 |
262 |
$0.00 |
| 90649 |
|
1,189 |
1,143 |
$0.00 |
| 90715 |
|
571 |
549 |
$0.00 |
| 90473 |
|
172 |
170 |
$0.00 |
| 90710 |
|
327 |
318 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
845 |
758 |
$0.00 |
| 90707 |
|
74 |
71 |
$0.00 |
| 90658 |
|
55 |
55 |
$0.00 |
| 90700 |
|
45 |
41 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
15 |
$0.00 |